Atorvastatin treatment modulates the gut microbiota of the hypercholesterolemic patients

OMICS A Journal of Integrative Biology

Volumn 22, Issue 2, 2018, Pages 154-163

  Khan, Tariq Jamal ^a   Ahmed, Youssri M ^a   Zamzami, Mazin A ^a   Siddiqui, Aisha M ^b   Khan, Imran ^c   Baothman, Othman A S ^a   Mehanna, Mohamed G ^a   Kuerban, Abudukadeer ^a   Kaleemuddin, Mohammed ^a   Yasir, Muhammad ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b King Abdulaziz University   (Saudi Arabia)

^c MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

atorvastatin; cardiovascular disease; gut microbiota; hypercholesterolemia; microbiome science

Indexed keywords

ANTIBIOTIC AGENT; ATORVASTATIN; BACTERIAL DNA; DNA 16S; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROBIOTIC AGENT; TRIACYLGLYCEROL; CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; RNA 16S;

AKKERMANSIA MUCINIPHILA; ARTICLE; BACTEROIDES OVATUS; BACTEROIDES VULGATES; BIFIDOBACTERIUM BIFIDUM; BILOPHILA WADSWORTHIA; BLAUTIA RUMINOCOCCUS TORQUES; CLINICAL ARTICLE; COLLINSELLA; COLLINSELLA AEROFACIENS; CONTROLLED STUDY; EUBACTERIUM RECTALE; FAECALIBACTERIUM PRAUSNITZII; FEMALE; HERBAL MEDICINE; HUMAN; HYPERCHOLESTEROLEMIA; INTESTINE FLORA; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; NONHUMAN; OSCILLOSPIRA; PRINCIPAL COORDINATE ANALYSIS; PRIORITY JOURNAL; STREPTOCOCCUS AUSTRALIS; STREPTOCOCCUS LUTETIENSIS; STREPTOCOCCUS PARASANGUINIS; STREPTOCOCCUS SANGUINIS; SUTTERELLA PARVIRUBRA; TANNERELLA; TOTAL CHOLESTEROL LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; ADULT; BACTERIUM; BLOOD; DRUG EFFECT; GENETICS; INFLAMMATION; LIPID METABOLISM; MICROBIOLOGY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; ANTICHOLESTEREMIC AGENTS; ATORVASTATIN; BACTERIA; CHOLESTEROL; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; HYPERCHOLESTEROLEMIA; INFLAMMATION; LIPID METABOLISM; MALE; MIDDLE AGED; RNA, RIBOSOMAL, 16S; YOUNG ADULT;

EID: 85042009624     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2017.0130     Document Type: Article

References (46)

1. Al-Nozha MM, Arafah MR, Al-Maatouq MA, et al. (2008). Hyperlipidemia in Saudi Arabia. Saudi Med J 29, 282-287
2. Al Rasadi K, Almahmeed W, Alhabib KF, Abifadel M, Farhan HA, and Alsifri S. (2016). Dyslipidaemia in the Middle East: Current status and a call for action. Atherosclerosis 252, 182-187
3. Boissiere A, Tchioffo MT, Bachar D, et al. (2012). Midgut microbiota of the malaria-mosquito vector Anopheles gambiae and interactions with Plasmodium falciparum infection. PLoS Pathog 8, e1002742
4. Candela M, Biagi E, Soverini M, et al. (2016). Modulation of gut microbiota dysbiosis in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet. Br J Nutr 116, 80-93
5. Cani PD, Bibiloni R, Knauf C, et al. (2008). Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481
6. Catry E, Pachikian BD, Salazar N, Neyrinck AM, Cani PD, and Delzenne NM. (2015). Ezetimibe and simvastatin modulate gut microbiota and expression of genes related to cholesterol metabolism. Life Sci 132, 77-84
7. Chan YK, El-Nezami H, Chen Y, Kinnunen K, and Kirjavainen PV. (2016). Probiotic mixture VSL#3 reduce high fat diet induced vascular inflammation and atherosclerosis in ApoE(-/-) mice. AMB Express 6, 61
8. Chen ML, Yi L, Zhang Y, et al. (2016). Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota. MBio 7, e02210-e02215
9. David LA, Maurice CF, Carmody RN, et al. (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559-563
10. Filippo C, Cavalieri D, Paola M, et al. (2010). Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107, 14691-14696
11. Dowd SE, Sun Y, Wolcott RD, Domingo A, and Carroll JA. (2008). Bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP) for microbiome studies: Bacterial diversity in the ileum of newly weaned Salmonella-infected pigs. Foodborne Pathog Dis 5, 459-472
12. Eren AM, Zozaya M, Taylor CM, Dowd SE, Martin DH, and Ferris MJ. (2011). Exploring the diversity of Gardnerella vaginalis in the genitourinary tract microbiota of monogamous couples through subtle nucleotide variation. PLoS One 6, e26732
13. Fei N, and Zhao L. (2013). An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J 7, 880-884
14. Fu ZD, Cui JY, and Klaassen CD. (2014). Atorvastatin induces bile acid-synthetic enzyme Cyp7a1 by suppressing FXR signaling in both liver and intestine in mice. J Lipid Res 55, 2576-2586
15. Gonzalez FJ, Jiang C, and Patterson AD. (2016). An intestinal microbiota-farnesoid X receptor axis modulates metabolic disease. Gastroenterology 151, 845-859
16. Gregory JC, Buffa JA, Org E, et al. (2015). Transmission of atherosclerosis susceptibility with gut microbial transplantation. J Biol Chem 290, 5647-5660
17. Jarocki P, Podlesny M, Glibowski P, and Targonski Z. (2014). A new insight into the physiological role of bile salt hydrolase among intestinal bacteria from the genus Bifidobacterium. PLoS One 9, e114379
18. Joyce SA, Macsharry J, Casey PG, et al. (2014). Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proc Natl Acad Sci U S A 111, 7421-7426
19. Karlsson FH, Fak F, Nookaew I, et al. (2012). Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun 3, 1245
20. Khan I, Azhar EI, Abbas AT, et al. (2016). Metagenomic analysis of antibiotic-induced changes in gut microbiota in a pregnant rat model. Front Pharmacol 7, 104
21. Kim SH, Jo SH, Lee SC, et al. (2016). Blood pressure and cholesterol-lowering efficacy of a fixed-dose combination with irbesartan and atorvastatin in patients with hypertension and hypercholesterolemia: A randomized, doubleblind, factorial, multicenter phase III study. Clin Ther 38, 2171-2184
22. Konikoff T, and Gophna U. (2016). Oscillospira: A central, enigmatic component of the human gut microbiota. Trends Microbiol 24, 523-524
23. Koren O, Spor A, Felin J, et al. (2011). Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A 108, 4592-4598
24. Lee H, and Ko G. (2014). Effect of metformin on metabolic improvement and gut microbiota. Appl Environ Microbiol 80, 5935-5943
25. Li J, Lin S, Vanhoutte PM, Woo CW, and Xu A. (2016). Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe-/-mice. Circulation 133, 2434-2446
26. Lukovac S, Belzer C, Pellis L, et al. (2014). Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. MBio 5, e01438-14
27. Luo P, Wang L, Zhu H, Du S, Wang G, and Ding S. (2016). Impact of atorvastatin combined with ezetimibe for the treatment of carotid atherosclerosis in patients with coronary heart disease. Acta Cardiol Sin 32, 578-585
28. Machiels K, Joossens M, Sabino J, et al. (2014). A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63, 1275-1283
29. Mahmoud MF, El-Nagar M, and El-Bassossy HM. (2012). Antiinflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats. Arch Pharm Res 35, 155-162
30. Masella AP, Bartram AK, Truszkowski JM, Brown DG, and Neufeld JD. (2012). PANDAseq: Paired-end assembler for illumina sequences. BMC Bioinformatics 13, 31
31. Millar JS, Ky B, Wolfe ML, Pruscino L, Baer A, and Rader DJ. (2010). Short-term treatment with high-dose atorvastatin reduces LDL cholesterol but shows no anti-inflammatory effects in normolipidemic subjects with normal CRP levels. Clin Transl Sci 3, 140-146
32. Nam YD, Jung MJ, Roh SW, Kim MS, and Bae JW. (2011). Comparative analysis of korean human gut microbiota by barcoded pyrosequencing. PLoS One 6, e22109
33. Organ CL, Otsuka H, Bhushan S, et al. (2016). Choline diet and its gut microbe-derived metabolite, trimethylamine N-oxide, exacerbate pressure overload-induced heart failure. Circ Heart Fail 9, e002314
34. Quevrain E, Maubert MA, Sokol H, Devreese B, and Seksik P. (2016b). The presence of the anti-inflammatory protein MAM, from Faecalibacterium prausnitzii, in the intestinal ecosystem. Gut 65, 882
35. Romano KA, Vivas EI, Amador-Noguez D, and Rey FE. (2015). Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio 6, e02481
36. Rossi O, Van Berkel LA, Chain F, et al. (2016). Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses. Sci Rep 6, 18507
37. Sayin SI, Wahlstrom A, Felin J, et al. (2013). Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 17, 225-235
38. Schneeberger M, Everard A, Gomez-Valades AG, et al. (2015). Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep 5, 16643
39. Sokol H, Pigneur B, Watterlot L, et al. (2008). Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105, 16731-16736
40. Swanson KS, Dowd SE, Suchodolski JS, et al. (2011). Phylogenetic and gene-centric metagenomics of the canine intestinal microbiome reveals similarities with humans and mice. ISME J 5, 639-649
41. Turnbaugh PJ, Ley RE, MahowaldMA,Magrini V, Mardis ER, and Gordon JI. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1131
42. Tyakht AV, Kostryukova ES, Popenko AS, et al. (2013). Human gut microbiota community structures in urban and rural populations in Russia. Nat Commun 4, 2469
43. Wahlstrom A, Sayin SI, Marschall HU, and Backhed F. (2016). Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab 24, 41-50
44. Xie G, Wang X, Liu P, et al. (2016). Distinctly altered gut microbiota in the progression of liver disease. Oncotarget 7, 19355-19366
45. Yatsunenko T, Rey FE, Manary MJ, et al. (2012). Human gut microbiome viewed across age and geography.Nature 486, 222-227
46. Yin J, Liao SX, He Y, et al. (2015). Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack. J Am Heart Assoc 4, e002699